Bortezomib Maintenance (Bm) Versus Consolidation (Bc) Following Aggressive Immunochemotherapy and Autologous Stem Cell Transplant (Asct) For Untreated Mantle Cell Lymphoma (Mcl): CALGB 50403
- Citation:
- Blood vol 126 (23) abstr 337
- Meeting Instance:
- ASH 2015
- Year:
- 2015
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 3168
- Pharmas:
- Grants:
- U10CA180821, U10CA180882
- Corr. Author:
- Authors:
- Lawrence D. Kaplan Wendy Stock Sin-Ho Jung Nancy Bartlett Brandy Pitcher John Byrd Kristie A. Blum Ann S. LaCasce Eric D. Hsi David Hurd Myron Czuczman John P. Leonard Bruce. D. Cheson
- Networks:
- CA824, CAPITAL, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-MO011, LAPS-NY158, LAPS-OH007, NC002, NY018, OH070
- Study
- CALGB-50403
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: